Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Association for Innovation and Biomedical Research on Light and Image
ClinicalTrials.gov Identifier:
NCT01298674
First received: February 15, 2011
Last updated: October 7, 2015
Last verified: October 2015
  Purpose
This is an epidemiological study to assess the the prevalence of Age-Related Macular (ARM) Degeneration in Portugal.

Condition
Age-Related Macular Degeneration
Other Ocular Disease Such as: Diabetic Retinopathy, Glaucoma, Cataract, Etc.

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal

Resource links provided by NLM:


Further study details as provided by Association for Innovation and Biomedical Research on Light and Image:

Primary Outcome Measures:
  • ARM [ Time Frame: 1 month after the screening ] [ Designated as safety issue: Yes ]
    Signs of Age-Related Macular Degeneration


Secondary Outcome Measures:
  • Other ocular disease [ Time Frame: 1 month after screening ] [ Designated as safety issue: Yes ]
    Signs of other ocular disease such as: diabetic retinopathy, glaucoma, cataract, etc.


Enrollment: 6023
Study Start Date: August 2009
Study Completion Date: October 2013
Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Participants with 55 or more years-old
Criteria

Inclusion Criteria:

  • Participants with 55 years-old

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01298674

Locations
Portugal
Health care units of Lousã and Trevim-Sol
Lousã, Coimbra, Portugal, 3200-201
ARS Centro - Centro de Saúde de Mira
Mira, Portugal
Sponsors and Collaborators
Association for Innovation and Biomedical Research on Light and Image
Investigators
Study Director: José Cunha-Vaz, MD, PhD Association for Innovation and Biomedical Research on Light and Image
Principal Investigator: Rufino Silva, MD, PhD Association for Innovation and Biomedical Research on Light and Image
  More Information

Responsible Party: Association for Innovation and Biomedical Research on Light and Image
ClinicalTrials.gov Identifier: NCT01298674     History of Changes
Other Study ID Numbers: CC-01-2009 
Study First Received: February 15, 2011
Last Updated: October 7, 2015
Health Authority: Portugal: AIBILI - Comissão de Ética para a Saúde

Additional relevant MeSH terms:
Glaucoma
Macular Degeneration
Cataract
Diabetic Retinopathy
Ocular Hypertension
Eye Diseases
Retinal Degeneration
Retinal Diseases
Lens Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 24, 2016